Metsera

Metsera CROIC

Delisted

The Cash Return on Invested Capital (CROIC) of Metsera (MTSR) as of Nov 3, 2026 is -33.76 %. In the previous year, Cash Return on Invested Capital (CROIC) was -35.96 % — a change of -6.13% (higher).

CROIC

-33.76 %

YoY

-6.13%

Last updated:

Cash Return on Invested Capital (CROIC) of Metsera is 2024 -33.76 % . Cash Return on Invested Capital (CROIC) of Metsera was 2023 -35.96 % . It decreases by -6.13% higher compared to the previous year.

The Metsera CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2022
-3.74 USD
Jan 1, 2023
-35.96 USD
Jan 1, 2024
-33.76 USD
The Metsera CROIC history
YEARCROICYoY
-33.76 %-6.13%
-35.96 %+862.11%
-3.74 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Metsera Stock analysis

What does Metsera do? Metsera Inc. is a clinical stage biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on Biotechnology. The company develops next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for treating obesity and related conditions. Utilizing its proprietary MINT peptide library, HALO half-life extension platform, and MOMENTUM oral delivery system, Metsera has a pipeline including MET-097i, MET-233i, and MET-224o, targeting various obesity treatments with differentiated approaches. Listed on 31 January 2025, the company employs 82 staff. Metsera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Metsera stock

Cash Return on Invested Capital (CROIC) of Metsera is -33.76 % in 2024.

Cash Return on Invested Capital (CROIC) of Metsera changed from -35.96 % to -33.76 %, representing a -6.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Metsera since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Metsera with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Metsera

All Key Metrics — Metsera